Research Hotspot

Distearyl Phthalic Acid Amides to Accelerate Cosmetics Formulation and Manufacture

Distearyl Phthalic Acid Amides to Accelerate Cosmetics Formulation and Manufacture

Distearyl Phthalic Acid Amide, also known as N, N-Stearyl Phthalic Acid Amide or N, N-Tollow Phthalic Acid Amide, is a biodegradable ingredient contained in many cosmetics and personal care products, […]

bacteria

Some Facts About HER2-Targeted Drugs

Drugs targeting HER2 have shown excellent clinical efficacy over the 20 years, achieving one milestone after another in the field of cancer therapeutics. This article mainly introduces the development history […]

Cancer

Discovery of BLU-945 Brings Hope to EGFR-Positive NSCLC Patients

Mutations in the epidermal growth factor receptor (EGFR) kinase domain are the oncogenic drivers of this adenocarcinoma. Tyrosine kinase inhibitors (TKIs), developed over the last two decades, targeting EGFR mutations, […]

DNA

FDA Approved Oligonucleotide Drugs

Why oligonucleotide drugs? Synthetic oligonucleotides are the key factor in almost all molecular biological methodologies. They are used in PCR, reverse transcription, sequencing, gene editing, synthetic biology, cloning, single nucleotide […]

drug

The Latest and Most Complete Collection of Cancer Drugs

1. Respiratory system 1.1. Lung cancer Drug Name Trade name CAS Target Description Approved Status Gefitinib lressa 184475-35-2 EGFR Gefitinib effectively inhibits all tyrosine phosphorylation sites on EGFR in both […]

drug

A Brief Discussion on ALK Inhibitors

In 2007, Japanese professors firstly discovered ALK rearrangement and identified the fusion of ALK and EML4 in non-small cell lung cancer specimens. EML4 can promote the activation of ALK kinase […]

drug

Introduction to Marketed Kinase Inhibitors

In 2001, the FDA approved Imatinib, the first drug to be developed by targeting a specific protein kinase and the first molecularly targeted drug to fight cancer. It was considered […]

molecular

Common Methods of Drug Analysis

Pharmaceutical analysis and testing can study the composition, physical and chemical properties, authenticity, purity, and the content of active ingredients of drugs, which ensures that people can use drugs reasonably […]

Cancer

Summary of Kinase Inhibitors | CDK2 and Its Inhibitors

CDKs belong to the serine/threonine protein kinase family, and their kinase activity requires binding to cyclins. Abnormalities in CDKs have been reported to cause proliferation, genomic and chromosomal instability that […]

drug

Research Progress of Small Molecule Inhibitors Targeting MYC

MYC protein is an inherently disordered protein, which lacks a hydrophobic pocket or groove suitable for binding small molecule compounds. Currently, no small molecule compounds that can bind MYC have […]